Luciano generated top-level financial performance while streamlining Schering’s business operations. He divested Schering’s non-healthcare related business lines and was one of the first pharmaceutical executives to recognize the potential for biotechnology. His early research focus on biotechnology enabled Schering to introduce some of the first commercially viable cancer treatment drugs.